Here's Why Cara Therapeutics Jumped 56.5% in the First Half of 2018

0
119

What happened Shares of Cara Therapeutics NASDAQ CARA 160 a clinical stage biotech developing novel pain management drugs soared 56 5 during the first half of 2018 according to data from S amp P Global Market Intelligence Two big announcements drove the stock

Source